Business ❯ Corporate Communications

Investor Relations

Press Releases Webcasts Financial Reporting Public Relations Conference Calls Financial Disclosures Stakeholder Engagement Media Resources Earnings Announcements Public Disclosure Market Signals Shareholder Engagement Data Formats Financial News Meeting Notices Company Announcements Public Statements Regulatory Filings Market Analysis Analyst Call Disclosure Practices Take-Two Interactive Market Reactions

Kyverna CAR-T Delivers Positive Phase 2 Topline in Stiff Person Syndrome as Shares Jump

The company now targets an FDA filing in early 2026 following significant Week 16 mobility gains with no high‑grade toxicities reported.

Olema Soars on Roche SERD Win, Then Slips on Planned Stock Offering

CSX Q3 Profit Falls on Goodwill Write-Down, Operations Show Early Gains Under New CEO

FDA Signals Openness to Accelerated Path for Lexeo’s Friedreich’s Ataxia Cardiac Gene Therapy